Navigating the risks in acute heart failure
نویسندگان
چکیده
منابع مشابه
Risks and Benefits of Risk Prediction in Acute Heart Failure.
SEE PAGE 737 D espite the remarkable advances in the treatment of acute and chronic heart failure (HF), prognosis assessment remains an ongoing challenge. Multiple cardiovascular diseases lead to the development of HF. Treatment options for these diseases are evolving, which leads to greater numbers of patients reaching the final state of HF at a later age with a greater comorbidity burden. The...
متن کاملNavigating the crossroads of coronary artery disease and heart failure.
Chronic heart failure (HF) affects 5 million patients in the United States and is responsible for 1 million hospitalizations and 300 000 deaths annually.1 The total annual costs associated with this disorder have been estimated to exceed $40 billion.1,2 Chronic HF is the only category of cardiovascular diseases for which the prevalence, incidence, hospitalization rate, total burden of mortality...
متن کاملAcute heart failure facts and numbers: acute heart failure populations
Acute heart failure (AHF) is a life-threatening emergency, which largely profits from early diagnosis and treatment. The prevalence of AHF is difficult to assess, estimates range between 1 and 12% in the general population. Despite recent therapeutic advances, in-hospital mortality is high with estimates varying from 4 and 18% in different registries. Due to large differences in AHF definitions...
متن کاملDevices in acute heart failure.
The optimal management strategy for patients with acutely decompensated heart failure has been limited to the use of various pharmacologic agents. However, with technological advances in mechanical devices, nonpharmacologic approaches now are available to supplement pharmacologic management. These devices range in sophistication and expertise and target various features of the acute heart failu...
متن کاملBiomarkers in acute heart failure.
The care of patients with acutely decompensated heart failure is being reshaped by the availability and understanding of several novel and emerging heart failure biomarkers. The gold standard biomarkers in heart failure are B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide, which play an important role in the diagnosis, prognosis, and management of acute decompensated hea...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal. Acute Cardiovascular Care
سال: 2020
ISSN: 2048-8734,2048-8726
DOI: 10.1177/2048872620941790